November 2, 2020
Use of Human Amniotic Based Products
CGS has seen multiple claims where cellular and/or tissue-based products (CTPs), specially micronized or particulated human amniotic membrane and/or placental tissue matrix, are being injected into joints and tissues for osteoarthritis, plantar fasciitis, and other complaints.
The indications for these products are to treat non-healing wounds and burn injuries and are intended for external application to the wound.
CGS covers the application of CTPs for ulcers or wounds as outlined in the LCD L36690 Wound Application of Cellular and/or Tissue-Based Products, Lower extremities.
Using these products topically or as an injection outside of the indicated use may not be a covered service. The use of these products outside of its indicated use may not be medically necessary and may be subject to medical review.